Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Industry Summary Page

Industry: pharmaceuticals
Penalty Total since 2000: $116,245,163,450
Number of Records: 1,270
Note: The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Johnson & Johnson$24,497,162,77088
Pfizer$10,948,368,52398
Merck$10,710,400,03189
Teva Pharmaceutical Industries$10,242,576,79696
GlaxoSmithKline$9,572,803,40650
Purdue Pharma$9,278,372,78711
AbbVie$7,560,456,40484
Takeda Pharmaceutical$3,987,516,44732
Endo International$3,311,990,66730
Eli Lilly$2,831,299,67626

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent ParentPrimary Offense TypeYearAgencyPenalty Amount sort icon
Intermune, Inc.RocheMedicare Coverage Gap Discount Program violation2013CMS$5,641
Amneal Pharmaceutical, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2015CMS$5,909
Amneal Pharmaceutical, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2015CMS$9,440
Amneal Pharmaceutical, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2016CMS$10,788
Amneal Pharmaceuticals, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2016CMS$12,367
Amneal Pharmaceuticals, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2019CMS$12,968
Intermune, Inc.RocheMedicare Coverage Gap Discount Program violation2013CMS$16,215
Alnylam Pharmaceuticals, Inc.Alnylam PharmaceuticalsMedicare Coverage Gap Discount Program violation2023CMS$31,959
Purdue Pharma, L.P.Purdue PharmaControlled Substances Act violation2015NY-AG$75,000
Wockhardt USAWockhardt LimitedMedicare Coverage Gap Discount Program violation2020CMS$111,824
Actavis Kadian, LLCAbbVieMedicare Coverage Gap Discount Program violation2013CMS$116,703
Sandoz, Inc.Sandoz GroupHHS civil monetary penalties2011HHSOIG$230,000
Mylan Specialty, L.P.Viatrisoff-label or unapproved promotion of medical products2013MA-AG$250,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2013MA-AG$375,000
ISTA Pharmaceuticals, Inc.Bausch Healthoff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $390,253
Johnson & JohnsonJohnson & JohnsonControlled Substances Act violation2008USAO$511,000
GlaxoSmithKlineGlaxoSmithKlineoff-label or unapproved promotion of medical products2009KY-AG$661,860
Purdue Frederick Company, Inc. and Purdue Pharma, L.P.Purdue PharmaControlled Substances Act violation2007NV-AG$1,047,787
Novo Nordisk Inc.Novo Holdings A/Soff-label or unapproved promotion of medical products2017CA-INS$1,100,000
Otsuka American Pharmaceutical Inc.Otsuka Pharmaceuticaloff-label or unapproved promotion of medical products2008MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,700,000
AndaTeva Pharmaceutical IndustriesControlled Substances Act violation2016WV-AG$1,800,000
Cypress Pharmaceutical Inc.Currax Pharmaceuticalsoff-label or unapproved promotion of medical products2012FDA$2,800,000
Glenmark Pharmaceuticals, Inc.Glenmark PharmaceuticalsHHS civil monetary penalties2015HHSOIG$2,887,300
Advanced Neuromodulation Systems, Inc.Abbott LaboratoriesHHS civil monetary penalties2007HHSOIG$2,950,000
Novo Nordisk Inc.Novo Holdings A/Soff-label or unapproved promotion of medical products2011MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,574,209
GlaxoSmithKlineGlaxoSmithKlineoff-label or unapproved promotion of medical products2010KY-AG$3,700,000
Otsuka American Pharmaceutical Inc.Otsuka Pharmaceuticaloff-label or unapproved promotion of medical products2008FDA$4,000,000
Medicis Pharmaceutical CorporationBausch Healthoff-label or unapproved promotion of medical products2007MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,000,000
Eisai Inc.Eisaioff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,658,249
AllerganAbbVieoff-label or unapproved promotion of medical products2022MULTI-AG$4,800,000
AstraZenecaAstraZenecaoff-label or unapproved promotion of medical products2013KY-AG$5,500,000
Inspire Pharmaceuticals Inc.Merckoff-label or unapproved promotion of medical products2015USAO$5,900,000
Janssen Ortho LLC and Janssen Pharmaceuticals, Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2014MT-AG$5,900,000
Inspire PharmaceuticalsMerckoff-label or unapproved promotion of medical products2015MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,000,000
Cephalon, Inc.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2008CT-AG$6,150,000
Novartis PharmaceuticalsNovartisoff-label or unapproved promotion of medical products2012TX-AG$6,638,250
InterMune Inc.Rocheoff-label or unapproved promotion of medical products2006MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,700,000
Allergan Ltd.AbbVieoff-label or unapproved promotion of medical products2022RI-AG$7,500,000
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022MULTI-AG$8,200,000
Endo PharmaceuticalsEndo InternationalControlled Substances Act violation2020OK-AG$8,750,000
Medicis Pharmaceutical CorporationBausch Healthoff-label or unapproved promotion of medical products2007DOJ_CIVIL$9,800,000
UCB Inc.UCBoff-label or unapproved promotion of medical products2011MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $9,893,322
Endo PharmaceuticalsEndo Internationaloff-label or unapproved promotion of medical products2022CA-SFCA$10,000,000
Eisai Inc.Eisaioff-label or unapproved promotion of medical products2010FDA$11,000,000
Sandoz, Inc.Sandoz GroupHHS civil monetary penalties2015HHSOIG$12,640,000
Eli Lilly and Co.Eli Lillyoff-label or unapproved promotion of medical products2009ID-AG$13,000,000
Boehringer Ingelheim Pharmaceuticals, Inc.Boehringer Ingelheimoff-label or unapproved promotion of medical products2017MULTI-AG$13,500,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2011FDA$14,500,000
Allergan Inc.AbbVieoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $14,750,000
GlaxoSmithKline, LLCGlaxoSmithKlineoff-label or unapproved promotion of medical products2013MD-AG$15,000,000
Janssen Pharmaceuticals, Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2013MA-AG$15,100,000
Eli LillyEli Lillyoff-label or unapproved promotion of medical products2010AR-AG$18,500,000
Eli LillyEli Lillyoff-label or unapproved promotion of medical products2010MS-AG$18,500,000
Genentech Inc.Rocheoff-label or unapproved promotion of medical products2000MULTI-AG$19,000,000
Bristol-Myers SquibbBristol-Myers Squibboff-label or unapproved promotion of medical products2016MULTI-AG$19,500,000
Purdue PharmaPurdue Pharmaoff-label or unapproved promotion of medical products2007MULTI-AG$19,500,000
Jazz Pharmaceuticals Inc.Jazz Pharmaceuticalsoff-label or unapproved promotion of medical products2007USAO$20,000,000
Eli LillyEli Lillyoff-label or unapproved promotion of medical products2010LA-AG$20,000,000
Celgene Corp.Bristol-Myers Squibboff-label or unapproved promotion of medical products2017MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000
Shire Pharmaceuticals LLCTakeda Pharmaceuticaloff-label or unapproved promotion of medical products2014MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,786,034
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022RI-AG$21,000,000
Par Pharmaceutical Companies Inc.Endo Internationaloff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,500,000
Ortho-McNeil Pharmaceutical LLCJohnson & Johnsonoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,681,516
Novo Nordisk Inc.Novo Holdings A/Soff-label or unapproved promotion of medical products2011FDA$25,000,000
Abbott LaboratoriesAbbott Laboratoriesoff-label or unapproved promotion of medical products2018USAO$25,000,000
Eli Lilly and Co.Eli Lillyoff-label or unapproved promotion of medical products2009CT-AG$25,100,000
AllerganAbbVieoff-label or unapproved promotion of medical products2022CA-SFCA$27,000,000
Teva ParmaceuticalsTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022CA-SFCA$27,000,000
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $29,000,000
OrganonOrganon & Co.off-label or unapproved promotion of medical products2014MULTI-AG$31,000,000
UCB Inc.UCBoff-label or unapproved promotion of medical products2011FDA$34,000,000
Mallinckrodt LLCMallinckrodtControlled Substances Act violation2017DEA$35,000,000
PfizerPfizeroff-label or unapproved promotion of medical products2014MULTI-AG$35,000,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2005FDA$36,000,000
InterMune Inc.Rocheoff-label or unapproved promotion of medical products2006FDA$36,900,000
AllerganAbbVieoff-label or unapproved promotion of medical products2024MD-AG$38,166,450
Janssen Pharmaceuticals/Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2022NH-AG$40,500,000
Johnson & JohnsonJohnson & Johnsonoff-label or unapproved promotion of medical products2022NH-AG$40,500,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2012MULTI-AG$42,900,000
Elan Corp.Perrigooff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $43,399,040
Par Pharmaceutical Companies Inc.Endo Internationaloff-label or unapproved promotion of medical products2013FDA$45,000,000
Allergan PLCAbbVieoff-label or unapproved promotion of medical products2023KY-AG$48,666,145
Endo Health SolutionsEndo Internationaloff-label or unapproved promotion of medical products2021NY-AG$50,000,000
Shire Pharmaceuticals LLCTakeda Pharmaceuticaloff-label or unapproved promotion of medical products2014FDA$56,500,000
Pfizer Inc.Pfizeroff-label or unapproved promotion of medical products2008MULTI-AG$60,000,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2008MULTI-AG$62,000,000
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc.Endo Internationaloff-label or unapproved promotion of medical products2022FL-AG$65,000,000
Endo Health Solutions and Endo PharmaceuticalsEndo Internationaloff-label or unapproved promotion of medical products2022FL-AG$65,000,000
AstraZeneca PharmaceuticalsAstraZenecaoff-label or unapproved promotion of medical products2011MULTI-AG$68,500,000
TevaTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2024MD-AG$70,281,867
Amgen Inc.Amgenoff-label or unapproved promotion of medical products2015MULTI-AG$71,000,000
Teva Pharmaceuticals, Inc.Teva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2023KY-AG$71,477,474
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010FDA$72,500,000
AllerganAbbVieoff-label or unapproved promotion of medical products2022WV-AG$78,000,000
Ortho-McNeil Pharmaceutical LLCJohnson & Johnsonoff-label or unapproved promotion of medical products2010FDA$81,000,000
Teva Pharmaceutical IndustriesTeva Pharmaceutical Industriesoff-label or unapproved promotion of medical products2022WV-AG$83,000,000
Scios Inc.Johnson & Johnsonoff-label or unapproved promotion of medical products2011FDA$85,000,000
Teva PharmaceuticalsTeva Pharmaceutical IndustriesControlled Substances Act violation2019OK-AG$85,000,000
Novartis Pharmaceuticals CorporationNovartisoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $88,258,694
Schering-Plough CorporationMerckoff-label or unapproved promotion of medical products2006MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $91,602,000
Boehringer Ingelheim Pharmaceuticals Inc.Boehringer Ingelheimoff-label or unapproved promotion of medical products2012FDA$95,000,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.